(Q44054406)

29 November 2017

title

Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma (English)

1 reference

29 November 2017

1 reference

fluticasone propionate

1 reference

1 reference

John H Brabson

1

1 reference

29 November 2017

Dennis Clifford

2

1 reference

29 November 2017

Edward Kerwin

3

1 reference

29 November 2017

Gordon Raphael

4

1 reference

29 November 2017

Pamela J Pepsin

5

1 reference

29 November 2017

Lisa D Edwards

6

1 reference

29 November 2017

Sharon Srebro

7

1 reference

29 November 2017

Kathleen Rickard

8

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Medicine

29 November 2017

published in

1 reference

29 November 2017

volume

113

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

15-21

1 reference

Low-dose inhaled corticosteroids and the prevention of death from asthma

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Airway inflammation in mild intermittent and in persistent asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Asthma controller medications: what do patients want?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Efficacy and safety of inhaled corticosteroids. New developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

Glucocorticosteroids inhibit leukotriene production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

A novel pharmacologic action of glucocorticosteroids on leukotriene C4 catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

The role and contribution of leukotrienes in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901099-9

10.1016/S0002-9343(02)01099-9

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference